Furthermore, a large proportion of women with GDM under glyburide treatment suffer from insulin secretion deficiency, due to elevated hormones in late pregnancy which aggravate glucose and lipid metabolism disorders (34), which may lead to the enhancement of fetal circumstance blood glucose and insulin level. The gene discussed is INS; the disease is gestational diabetes.